Showing 1051-1060 of 4012 results for "".
Overcoming Barriers to Postpartum Depression Care in Rural Communities
https://reachmd.com/programs/advances-in-womens-health/overcoming-barriers-to-postpartum-depression-care-in-rural-communities/32753/Stigma and lack of healthcare access are just a few of the challenges women in U.S. rural communities face when coping with postpartum depression. Fortunately, there are several screening and treatment interventions we can implement to address these barriers to care, like utilizing community healthPreventing Injuries in Competitive Cyclists
https://reachmd.com/programs/clinicians-roundtable/preventing-injuries-in-competitive-cyclists/3144/In many regions of our country, summer weather means more outdoor activities, competitive cycling among them. Though cycling is great exercise, our patients must take proper caution to limit their injury risk. Host Dr. Sherwin Ho talks with Dr. Bill Bryan, former medical doctor for the United StatesChronic Traumatic Encephalopathy in Elite Athletes
https://reachmd.com/programs/focus-on-sports-medicine/chronic-traumatic-encephalopathy-in-elite-athletes/3989/Many elite athletes dedicate their lives to sport. In a high-impact game like football, the physical toll of this dedication can be devastating. One example of this is chronic traumatic encephalopathy, a form of brain damage most commonly linked to boxing. Now, a group of pro football players and otIs the Brain Changed by Treatment?
https://reachmd.com/programs/clinicians-roundtable/is-the-brain-changed-by-treatment/1616/What really happens in the brain when we prescribe an antidepressant? Is the brain changed forever? Dr. Clint Kilts from Emory University joins host Dr. Leslie Lundt to explain what we know about how the brain responds to antidepressants and psychotherapy.Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/kappa-free-light-chain-index-in-the-diagnosis-of-multiple-sclerosis/54598/Adoption of the kappa free light chain index can enhance diagnostic accuracy and reduce latency in multiple sclerosis diagnosis, complementing MRI and expert assessment in clinical decision-making.Strengthening Pediatric Immunization Against DTaP, Hepatitis B, and Polio
https://reachmd.com/programs/vaccination/strengthening-pediatric-immunization-against-dtap-hepatitis-b-and-polio/37109/Vaccines for diphtheria, tetanus, pertussis, hepatitis B, and polio form the foundation of early childhood immunization, but gaps in coverage continue to put children and communities at risk. Fortunately, combination vaccines and coadministration strategies can help providers minimize missed opportuWhat's New in Allergy Diagnostic Testing?
https://reachmd.com/programs/hot-topics-in-allergy/whats-new-in-allergy-diagnostic-testing/3920/The Joint Task Force on Practice Parameters for the Diagnosis and Treatment of Asthma has revised its allergy diagnostic testing parameters. What are the parameters trying to establish? What are the advantages of intracutaneous, skin prick, and in vitro testing for diagnosing allergies? Dr. I. LeonaIntegrity With Industry
https://reachmd.com/programs/practical-dermatology/program-name/39883/Former Chair of the Board of Directors for the National Psoriasis Foundation Colby Evans, MD, provides an update on the SAFE Step Act, and Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, is joined by Jules Lipoff, Clinical Associate Professor (Adjunct) in the Lewis Katz School of MDiabetic Retinopathy: Types, Causes, and Associated Somatic Changes
https://reachmd.com/programs/revealing-retina/diabetic-retinopathy-types-causes-and-associated-somatic-changes/5625/The eyes can yield clues to vascular issues elsewhere in the body. How can the two forms of diabetic retinopathy, which are non-proliferative and proliferative, affect vision, and how might retinopathy be associated with somatic effects resulting from diabetes? Dr. Alan Ruby, opthamologist and cliniInvesting in Cures for Multiple Sclerosis
https://reachmd.com/programs/clinicians-roundtable/investing-in-cures-for-multiple-sclerosis/3602/Through a venture philanthropy called Fast Forward, LLC the National Multiple Sclerosis Society plans to deploy 1.5 to 2 million dollars in the next 18 months as seed funding to biotech companies on the path towards cures for Multiple Sclerosis. Our guest, Timothy Coetzee executive director of Fast